K-NBC3: A Unique Protein with Potential Drug Targets (G9498)

Target Name: SLC4A8

NCBI ID: G9498

K-NBC3: A Unique Protein with Potential Drug Targets

SLC4A8 (K-NBC3) is a gene that encodes a protein known as K-NBC3. K-NBC3 is a member of the K-type nucleosome maintenance protein family, which is a family of proteins that help keep the nuclear genome in proper order. This gene has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The K-NBC3 gene was first identified in 2001 by researchers using techniques such as PCR and gene sequencing. The gene is located on chromosome 16 and has been shown to encode a protein with multiple unique features, including a long N-terminus, a nuclear localization signal, and a unique topology of the nucleosome. These features make K-NBC3 a unique protein that is not found in any other known gene products.

K-NBC3 has been shown to play a role in the regulation of nuclear chromatin structure and the maintenance of nuclear genomic stability. It is a key component of the nucleosome, which is the basic unit of the nuclear genome. The nucleosome is responsible for organizing the DNA in a specific configuration that is important for the expression of genes.

K-NBC3 is also shown to be involved in the regulation of gene expression. By interacting with the protein p21, K-NBC3 has been shown to play a role in the negative regulation of gene expression. This means that when K-NBC3 is active, it can prevent the activation of certain genes, thereby controlling the expression of proteins that are important for disease progression.

In addition to its role in gene regulation, K-NBC3 has also been shown to be involved in the development and progression of certain diseases. For example, K-NBC3 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This is because K-NBC3 is often expressed in the brains of individuals with these conditions and has been shown to play a role in the regulation of neurodegeneration.

Furthermore, K-NBC3 has also been shown to be involved in the regulation of cancer cell growth and metastasis. This is because K-NBC3 has been shown to play a role in the regulation of cell cycle progression and the association with cancer.

In conclusion, SLC4A8 (K-NBC3) is a unique and highly conserved protein that has been identified as a potential drug target or biomarker for several diseases. Its unique features, including its long N-terminus and unique topology, make it a unique protein that is not found in any other known gene products. K-NBC3 has been shown to play a role in the regulation of nuclear chromatin structure and the maintenance of nuclear genomic stability, as well as in the regulation of gene expression and the development and progression of certain diseases. Further research is needed to fully understand the role of K-NBC3 in these processes and to determine its potential as a drug target or biomarker.

Protein Name: Solute Carrier Family 4 Member 8

Functions: Mediates electroneutral sodium- and carbonate-dependent chloride-HCO3(-) exchange with a Na(+):HCO3(-) stoichiometry of 2:1 (PubMed:18577713). Plays a major role in pH regulation in neurons (By similarity). Mediates sodium reabsorption in the renal cortical collecting ducts (By similarity)

More Common Targets